Pharma

Your Article Summary

See Latest Articles

Baxter Announces Launch of BAXJECT(R) II Needle-Less Transfer Device for ADVATE(R)
Corporate News Releases - The Healthcare Sales & Marketing Network, 10/12/06

Baxter Healthcare Corporation announced the availability of BAXJECT II, an innovative needle-less transfer device designed to make the reconstitution and mixing of hemophilia factor therapies easier, faster and safer (as compared to the original BAXJECT and needles). BAXJECT II is the newest convenience feature to be added to ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin- Free Method], the only factor VIII therapy free of blood-based additives

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Roche Introduces New Automated Clinical Laboratory System for CE-Marked Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae
Roche, 12/10/09

EHRs Certified Under 2011 Criteria
HealthDataManagement, 12/10/09

Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
Genentech, 12/08/09

 See all of Medical Devices/Products